This protocol includes studies investigating the mechanisms involved in the integration of sensory information and central motor commands for the control of speech. Various hypotheses are being investigated with the common aim of improving our understanding of the processes and mechanisms underlying normal and disordered...
Patients ages 8 – 17 with newly diagnosed type 1 diabetes have an opportunity to participate in the PROTECT Study, a clinical trial to see if a study drug called teplizumab can safely preserve insulin-producing cells. Previous clinical studies have suggested a benefit of teplizumab in...
Our team is the NeuDLL (Neurodevelopmental Disorders Language & Learning) Lab in the UW Speech & Hearing Department. We are seeking families to participate in research related to spoken language in children with and without developmental disorders. Our current study focuses on how children learn words...
